Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002980 · ClinicalTrials.gov registry record · Phase 1
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer
A Phase 1 study, sponsored by California Cancer Consortium.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00002980: Completed Phase 1 study, sponsored by California Cancer Consortium.
NCT00002980 is a Phase 1 study that has completed, run by California Cancer Consortium. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002980, a Phase 1 study, has completed, sponsored by California Cancer Consortium.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of decitabine in treating patients with stage III or stage IV melanoma or other advanced cancer that has not responded to previous therapy.
Interventions
- DRUG decitabine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-05 |
| Phase | Phase 1 |
What the finished NCT00002980 record still lists
NCT00002980 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which decitabine is the first listed.
NCT00002980 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002980 about?
NCT00002980 is a clinical study titled "Decitabine in Treating Patients With Melanoma or Other Advanced Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of decitabine in treating patients with stage III or stage IV melanoma or other advanced cancer that has not responded to previou...
What is the current status of trial NCT00002980?
This trial is currently completed. It is a Phase 1 study. The study started on 1997-05.
What interventions are being tested in trial NCT00002980?
The interventions under investigation include: decitabine (DRUG).
Who is sponsoring clinical trial NCT00002980?
This trial is sponsored by California Cancer Consortium, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia